Stockhouse.com uses cookies on this site. By continuing to use our service, you agree to our use of cookies. Cookies are used to offer you a better browsing experience and to analyze our traffic. We also use them to share usage information with our partners. See full details.
I Agree
×
Join today and have your say! It’s FREE!

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Please Try Again
{{ error }}
By providing my email, I consent to receiving investment related electronic messages from Stockhouse.

or

Privacy Policy | Disclaimer

Sign In

Please Try Again
{{ error }}
Password Hint : {{passwordHint}}
Forgot Password?

or

Privacy Policy | Disclaimer
Please Try Again {{ error }}

Send my password

Return to Login
SUCCESS
An email was sent with password retrieval instructions. Please go to the link in the email message to retrieve your password.

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Quote  |  Bullboard  |  News  |  Opinion  |  Profile  |  Peers  |  Filings  |  Financials  |  Options  |  Price History  |  Ratios  |  Ownership  |  Insiders  |  Valuation

Breaking & Recent News Alpha Tau Medical Ltd DRTS

Healthcare Medical Devices
Alpha Tau Medical Ltd is an Israel-based medical technology company that focuses on research, development and commercialization of Alpha DaRT Diffusing Alpha-emitters Radiation Therapy (Alpha DaRT) for the treatment of solid cancer. Company's technology relies on the diffusion of atoms that emit alpha particles within the tumor tissue, and enables alpha radiation to reach the the entire tumor... see more

Recent & Breaking News (NDAQ:DRTS)

Alpha Tau Treats First Patient with Advanced Inoperable Pancreatic Cancer at Israel's Hadassah Medical Center

GlobeNewswire September 14, 2023

Alpha Tau Medical Announces Second Quarter 2023 Financial Results and Provides Corporate Update

GlobeNewswire August 28, 2023

Alpha Tau Medical to Participate in September Investor Conferences

GlobeNewswire August 24, 2023

Alpha Tau Announces Robust Long-Term Safety and Efficacy Data from Multiple Clinical Trials of Alpha DaRT

GlobeNewswire August 17, 2023

Alpha Tau Medical to Present at the Emerging Growth Conference on August 9th, 2023

GlobeNewswire August 2, 2023

Alpha Tau Medical to Participate in June Investor Conferences

GlobeNewswire May 24, 2023

Alpha Tau Medical Announces First Quarter 2023 Financial Results and Provides Corporate Update

GlobeNewswire May 23, 2023

Alpha Tau Expands its Alpha DaRT Treatment to Vulvar Cancer in Novel Clinical Trial with Cambridge University

GlobeNewswire May 17, 2023

Alpha Tau Announces the Publication of its US Multicenter Pilot Skin Cancer Trial Results in JAMA Network Open

GlobeNewswire May 11, 2023

Alpha Tau Medical to Present at Guggenheim Radiopharmaceuticals Day

GlobeNewswire May 3, 2023

Alpha Tau and the JGH Announce Alpha DaRT Treatment of First Patient in its Advanced Pancreatic Cancer Clinical Trial

GlobeNewswire April 3, 2023

Alpha Tau Medical to Present at Jefferies Radiopharma Innovation Summit

GlobeNewswire March 29, 2023

Alpha Tau Medical Confirms No Direct Exposure to Silicon Valley Bank

GlobeNewswire March 12, 2023

Alpha Tau Medical Announces Full Year 2022 Financial Results and Provides Corporate Update

GlobeNewswire March 9, 2023

Alpha Tau Announces Alpha DaRT(TM) Treatment of First Two Patients in its Pivotal Multicenter Recurrent Skin Cancer (ReSTART) Trial

GlobeNewswire March 8, 2023

Alpha Tau Announces Grant of Expanded Radioactive License and Final Pre-Clinical Laboratory Regulatory Approval at its Jerusalem Headquarters

GlobeNewswire March 3, 2023

Alpha Tau Announces Health Canada Authorization for Alpha DaRT Clinical Trial for the Treatment of Liver Metastases

GlobeNewswire March 1, 2023

Alpha Tau to Participate in Citi's 2023 Healthcare Services, Medtech, Tools & HCIT Conference

GlobeNewswire February 21, 2023

Alpha Tau to Present at Biotech Showcase and Participate in LifeSci Advisors Corporate Access Event During J.P. Morgan Healthcare Conference in San Francisco in January 2023

GlobeNewswire December 13, 2022

Alpha Tau Medical Announces Third Quarter 2022 Financial Results and Provides Corporate Update

GlobeNewswire November 22, 2022